What Confusion About Health Insurance Looks Like In The Doctor’s Office

September 29, 2017 – “As the country considers ways to once again reform its healthcare system, we have to remember that competition among insurance companies can become so confusing as to bewilder patients and physicians, thereby thwarting their ability to get affordable treatments for people with serious illnesses like rheumatoid arthritis. When it comes to…

6 Steps to Harness Account-Based Marketing within Pharma

Marketing to the Pharma Sector can be quite challenging in today’s environment. Unlike normal B2B structures, these huge targets are comprised of some of the largest most profitable brands in the world, operating in arguably the most regulated sector imaginable. If this is not intimidating enough, some of these individual companies are comprised of over…

Are DTC TV Ads "Scaring" Patients?

A recent BBC article (“Medicine Information Leaflets ‘Too Scary’ says Experts”) illustrated how word choice and framing of side effects on drug inserts may sway patients towards not taking their medication. But why? The Academy of Medical Sciences report, which the BBC quotes, shares that patients may be confused, anxious, and/or off-put by the current…

Ling 101: Power and Agency

Welcome back! At this point, we’ve covered a good amount of ground on the basics of healthcare discourse analysis. Namely we’ve talked about how linguistics: is integral to good market understanding, can shape understanding with footing and alignment has rules that we can break or follow But what about power and control?

Ling 101: Rules of Communication

Are you ready to find out more about discourse analysis in healthcare? We’ve already discussed how linguistics is integral to good market understanding, and how discourse analysis helps shape that understanding with footing and alignment, but what else can we learn? In this Ling 101 mini-lesson, we look at understanding the in-office conversational rules, how we…

Trends in Oncology: Metaphor Basics

The treatment discussion as a whole has been impacted by the launch of new classes of treatment and new products over the past year. One third (10/30) of newly approved molecules in the European Union in 2016 were drugs for use in oncology. As we continue our look at trends across Verilogue’s conversation database, one…

World MS Day 2017 – MS in the Exam Room

In support of World MS Day, we created a short video highlighting the key characteristics of in-office conversations between Physicians and Patient diagnosed with Multiple Sclerosis. Through our invaluable partnerships with the healthcare industry, we are excited to continue our efforts to improve the MS patient experience, one conversation at a time.